Bryan, Garnier & Co downgraded shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) from a buy rating to a neutral rating in a research report released on Thursday morning, MarketBeat Ratings reports. A number of other equities research analysts also recently commented on the company. Cantor Fitzgerald reaffirmed an overweight rating and issued a $65.00 […]